246 related articles for article (PubMed ID: 25052473)
1. Estrogen and its role in thyroid cancer.
Derwahl M; Nicula D
Endocr Relat Cancer; 2014 Oct; 21(5):T273-83. PubMed ID: 25052473
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor subtype expression and regulation is altered in papillary thyroid cancer after menopause.
Rubio GA; Catanuto P; Glassberg MK; Lew JI; Elliot SJ
Surgery; 2018 Jan; 163(1):143-149. PubMed ID: 29128169
[TBL] [Abstract][Full Text] [Related]
3. Oestrogen action on thyroid progenitor cells: relevant for the pathogenesis of thyroid nodules?
Xu S; Chen G; Peng W; Renko K; Derwahl M
J Endocrinol; 2013 Jul; 218(1):125-33. PubMed ID: 23645248
[TBL] [Abstract][Full Text] [Related]
4. The p75 neurotrophin receptor is widely expressed in conventional papillary thyroid carcinoma.
Rocha AS; Risberg B; Magalhães J; Trovisco V; de Castro IV; Lazarovici P; Soares P; Davidson B; Sobrinho-Simões M
Hum Pathol; 2006 May; 37(5):562-8. PubMed ID: 16647954
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions.
Kawabata W; Suzuki T; Moriya T; Fujimori K; Naganuma H; Inoue S; Kinouchi Y; Kameyama K; Takami H; Shimosegawa T; Sasano H
Mod Pathol; 2003 May; 16(5):437-44. PubMed ID: 12748250
[TBL] [Abstract][Full Text] [Related]
6. Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells.
Mitsutake N; Knauf JA; Mitsutake S; Mesa C; Zhang L; Fagin JA
Cancer Res; 2005 Mar; 65(6):2465-73. PubMed ID: 15781663
[TBL] [Abstract][Full Text] [Related]
7. Sexual dimorphism and thyroid dysfunction: a matter of oxidative stress?
Fortunato RS; Ferreira AC; Hecht F; Dupuy C; Carvalho DP
J Endocrinol; 2014 May; 221(2):R31-40. PubMed ID: 24578296
[TBL] [Abstract][Full Text] [Related]
8. [The mitogen-activated protein kinase (MAPK) signaling pathway in papillary thyroid cancer. From the molecular bases to clinical practice].
Zafon C; Obiols G
Endocrinol Nutr; 2009 Apr; 56(4):176-86. PubMed ID: 19627734
[TBL] [Abstract][Full Text] [Related]
9. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of oestrogen receptors in 351 human thyroid glands.
Tavangar SM; Monajemzadeh M; Larijani B; Haghpanah V
Singapore Med J; 2007 Aug; 48(8):744-7. PubMed ID: 17657383
[TBL] [Abstract][Full Text] [Related]
11. Is gender difference in postnatal thyroid growth associated with specific expression patterns of androgen and estrogen receptors?
Stanley JA; Aruldhas MM; Yuvaraju PB; Banu SK; Anbalagan J; Neelamohan R; Annapoorna K; Jayaraman G
Steroids; 2010 Dec; 75(13-14):1058-66. PubMed ID: 20670640
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo.
Ouyang B; Knauf JA; Smith EP; Zhang L; Ramsey T; Yusuff N; Batt D; Fagin JA
Clin Cancer Res; 2006 Mar; 12(6):1785-93. PubMed ID: 16551863
[TBL] [Abstract][Full Text] [Related]
13. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
[TBL] [Abstract][Full Text] [Related]
14. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between PI3K and estrogen in the mouse thyroid predisposes to the development of follicular carcinomas with a higher incidence in females.
Antico-Arciuch VG; Dima M; Liao XH; Refetoff S; Di Cristofano A
Oncogene; 2010 Oct; 29(42):5678-86. PubMed ID: 20676139
[TBL] [Abstract][Full Text] [Related]
16. Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer.
Chen GG; Vlantis AC; Zeng Q; van Hasselt CA
Curr Cancer Drug Targets; 2008 Aug; 8(5):367-77. PubMed ID: 18690843
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma.
Santarpia L; Myers JN; Sherman SI; Trimarchi F; Clayman GL; El-Naggar AK
Cancer; 2010 Jun; 116(12):2974-83. PubMed ID: 20564403
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
Xu X; Quiros RM; Gattuso P; Ain KB; Prinz RA
Cancer Res; 2003 Aug; 63(15):4561-7. PubMed ID: 12907632
[TBL] [Abstract][Full Text] [Related]
19. RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose.
Hamatani K; Eguchi H; Ito R; Mukai M; Takahashi K; Taga M; Imai K; Cologne J; Soda M; Arihiro K; Fujihara M; Abe K; Hayashi T; Nakashima M; Sekine I; Yasui W; Hayashi Y; Nakachi K
Cancer Res; 2008 Sep; 68(17):7176-82. PubMed ID: 18757433
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and progesterone receptors in neoplastic and non-neoplastic thyroid lesions.
Lewy-Trenda I
Pol J Pathol; 2002; 53(2):67-72. PubMed ID: 12140869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
